This story is part of CBC Health’s Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven’t subscribed yet, you can …
Pfizer said on Wednesday that Canada’s health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision. The …
MPs on the House of Commons health committee voted Wednesday to launch a study into the more than $300 million the Liberal government paid to a now-shuttered Quebec-based pharmaceutical company whose …